S. Bergstra

发表

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

A. Iagnocco, D. M. van der Heijde, R. Landewé, 2022, Annals of the Rheumatic Diseases.

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.

C. Turesson, X. Mariette, K. Pavelka, 2020, Rheumatology.

Country-level socioeconomic status relates geographical latitude to the onset of RA: a worldwide cross-sectional analysis in the METEOR registry

R. Landewé, A. Chopra, K. Salomon-Escoto, 2023, Annals of the Rheumatic Diseases.

Further Treatment Intensification in Undifferentiated and Rheumatoid Arthritis Patients Already in Low Disease Activity has Limited Benefit towards Physical Functioning

C. Allaart, R. Landewé, N. Riyazi, 2017, Arthritis Research & Therapy.

Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry

C. Allaart, R. Landewé, J. Branco, 2018, Annals of the rheumatic diseases.

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

D. M. van der Heijde, R. Landewé, J. Schoones, 2022, Annals of the Rheumatic Diseases.

After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries

B. Leeb, K. Pavelka, D. Courvoisier, 2022, Annals of the Rheumatic Diseases.

FRI0125 INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE EFFECTIVENESS OF TOCILIZUMAB ON INHIBITING RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS

T. Huizinga, D. Veale, J. D. da Silva, 2019, Poster Presentations.

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration

B. Leeb, K. Pavelka, M. Santos, 2022, Annals of the Rheumatic Diseases.

The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial

J. D. de Vries-Bouwstra, C. Allaart, S. A. Bergstra, 2022, Rheumatology.

Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis.

P. Dönnes, C. Wijbrandts, P. Tak, 2019, Seminars in arthritis and rheumatism.

A systematic review into the effectiveness of hand exercise therapy in the treatment of rheumatoid arthritis

S. Bergstra, A. T. Velde, Alessio Murgia, 2014, Clinical Rheumatology.

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

D. M. van der Heijde, R. Landewé, J. Schoones, 2022, Annals of the Rheumatic Diseases.

Meta‐Regression of a Dose‐Response Relationship of Methotrexate in Mono‐ and Combination Therapy in Disease‐Modifying Antirheumatic Drug–Naive Early Rheumatoid Arthritis Patients

T. Stijnen, C. Allaart, S. A. Bergstra, 2016, Arthritis care & research.

Joint inflammation tends to recur in the same joints during the rheumatoid arthritis disease course

Y. Goekoop-Ruiterman, C. Allaart, T. Huizinga, 2021, Annals of the Rheumatic Diseases.

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

C. Allaart, W. Lems, M. Boers, 2022, Annals of the Rheumatic Diseases.

Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up

C. Allaart, R. Cate, D. Schonenberg-Meinema, 2023, Pediatric Rheumatology.

Phenotype and treatment of elderly onset compared to younger onset rheumatoid arthritis patients in international daily practice.

C. Allaart, T. Huizinga, A. Chopra, 2021, Rheumatology.

EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology

M. D. de Wit, R. Landewé, P. Machado, 2022, Annals of the Rheumatic Diseases.

Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology

M. D. de Wit, R. Landewé, P. Machado, 2021, RMD Open.

TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years

C. Allaart, P. Kerstens, W. Lems, 2018, Rheumatology.

PATIENT-REPORTED OUTCOMES ABOUT QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATION MYOPATHY

J. Ciaffi, S. Liem, T. Huizinga, 2023 .

Socioeconomic deprivation and its relationship with worse disease outcomes in rheumatoid arthritis: impact beyond traditional risk factors

S. Bergstra, 2023, Rheumatology.

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis

C. Allaart, P. Kerstens, W. Lems, 2018, RMD Open.

Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study

C. Allaart, J. V. van Groenendael, T. Huizinga, 2017, Annals of the rheumatic diseases.

The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis

J. D. de Vries-Bouwstra, T. V. Vliet Vlieland, S. A. Bergstra, 2023, Journal of scleroderma and related disorders.

Patterns of clinical joint inflammation in juvenile idiopathic arthritis

C. Allaart, M. V. van Rossum, L. V. van Suijlekom-Smit, 2023, RMD Open.

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?

Y. Goekoop-Ruiterman, C. Allaart, P. Kerstens, 2020, RMD open.

SAT0529 Prolonged tnf-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up

C. Allaart, P. Kerstens, M. Kloppenburg, 2017 .

Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis

C. Allaart, R. Landewé, F. Buttgereit, 2022, Annals of the Rheumatic Diseases.

Mouth opening in systemic sclerosis: Its course over time, determinants and impact on mouth handicap

J. D. de Vries-Bouwstra, T. Huizinga, N. Ajmone Marsan, 2022, Journal of scleroderma and related disorders.

Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study

C. Allaart, S. M. van der Kooij, J. A. van der Pol, 2024, RMD open.

The association between increased body mass index and response to conventional synthetic DMARD treatment in rheumatoid arthritis: Results from the METEOR database.

R. Moots, R. Landewé, N. Goodson, 2021, Rheumatology.

Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry

C. Allaart, T. Huizinga, S. A. Bergstra, 2020, RMD Open.

Running with a minimalist shoe increases plantar pressure in the forefoot region of healthy female runners.

K Postema, E. R. van den Heuvel, K. Postema, 2015, Journal of science and medicine in sport.

How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies

C. Allaart, R. Landewé, A. Chopra, 2018, Annals of the rheumatic diseases.

Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort

Y. Goekoop-Ruiterman, C. Allaart, T. Huizinga, 2023, Annals of the Rheumatic Diseases.